Autism and OCD Research Fellowship

Total Page:16

File Type:pdf, Size:1020Kb

Autism and OCD Research Fellowship Autism and OCD Research Fellowship Our program is currently recruiting MD candidates for research fellowships. Program Description We are located in the Psychiatry Research Institute at Montefiore Einstein (PRIME) at the Albert Einstein College of Medicine and aim to develop innovative, novel and breakthrough treatments for unique overlapping conditions; and to clarify underlying mechanisms that underlie core symptom domains across these conditions. Our Autism and Obsessive Compulsive Spectrum Program focuses on Autism Spectrum Disorders (ASD), Prader-Willi Syndrome (PWS), and Obsessive Compulsive Spectrum Disorders such as Obsessive Compulsive Disorder (OCD), Body Dysmorphic Disorder (BDD), Intermittent Explosive Disorder (IED) and Tourette Syndrome (TS). Our work seeks to bridge and translate basic neuroscience discoveries into innovative experimental therapeutics and new clinical treatments. Dr. Eric Hollander is a Professor of Psychiatry and Behavioral Sciences and the Director of the Autism and OCD Program at Albert Einstein College of Medicine and Montefiore Medicine. He has been the PI of 10 federal grants, authored 528 publications, has 22,574 citations and an h-index of 84. He was chair of the DSM-5 Research Planning Agenda for Obsessive Compulsive and Related Disorder; was director and PI of the NIH STAART Autism Center of Excellence, and PI of the NIMH Psychopharmacology Training Fellowship. The program has received funding from the Department of Defense, and the Orphan Products Division of FDA, for autism, body dysmorphic disorder, and Prader Willi Syndrome. We were recently awarded funding by the Department of Defense Autism Research Program to study Cannabidivarin (CBDV) vs. Placebo in Children with Autism Spectrum Disorder (ASD). The primary aim is to compare changes in irritability from baseline to endpoint between the treatment and placebo groups. The secondary aims include comparing repetitive behaviors, social communication, quality of life, and adaptive behavior. We also received funding from the Orphan Products Division of the Food and Drug Administration to study Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Children and Adolescents with Prader-Willi Syndrome (PWS). In this study we will determine if intranasal oxytocin is effective in reducing hyperphagia in PWS. We also received funding from Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the National Institutes of Health, to study Long-term Antipsychotic Pediatric Safety (LAPS). In this trial the primary objective is evaluate the long-term pathologic weight changes associated with multi-year risperidone or aripiprazole therapy in 3 –18 y.o. children who have varying durations of prior antipsychotic drug exposure from the start of study Month 0 (M0). Our program works with industry sponsors: GW Pharmaceuticals, Sunovion Pharmaceuticals, F. Hoffmann-La Roche Ltd, Curemark LLC, Takeda, Avanir Pharmaceuticals, Neurocrine Biosciences, Pfizer, Forest Research Institute (now Allergan), Transcept Pharmaceuticals, and Coronado Biosciences. Foundations that have provided funding for our research include the Foundation for Prader-Willi Research and the Simons Foundation Autism Research Initiative (SFARI). Fellowship Description We are seeking a full-time fellow to work with our interdisciplinary team of physicians and psychologists on novel pharmacological studies for the treatment of Autism, Prader-Willi Syndrome, OCD and related disorders. The research fellow will work directly under the Principal Investigator and Director, Dr. Eric Hollander. Applicant Requirements Applicants must have an MD Applicants should have a demonstrated interest in psychiatry research 1-year to 3-year fellowship opportunities are available To apply, please send CV and Letter of Interest to [email protected] .
Recommended publications
  • Body Dysmorphic Disorder the Drive for Perfection
    1.0 ANCC CONTACT HOUR Body dysmorphic disorder The drive for perfection BY AMANDA PERKINS, DNP, RN Abstract: Body dysmorphic disorder EVERYTHING AROUND US focuses on (BDD) is an obsessive-compulsive and beauty, from commercials to magazines, related disorder that pushes people social media to movies. Already beauti- toward perfection, affecting 5 to 7.5 ful models are airbrushed to make them million people in the US. Individuals look “perfect” in a way that is unattain- with BDD spend a great deal of time able. People can easily apply filters to focusing on perceived flaws and ways in their selfies, removing even the slightest which to hide these flaws. The time imperfections. In this way, our society spent on these negative thoughts can 1 interfere with quality of life and the reinforces the need to be beautiful. ability to carry out daily tasks. This article Body dysmorphic disorder (BDD) is a discusses BDD, including symptoms, body image disorder that pushes people diagnosis, treatment, complications, and toward perfection, affecting approxi- the nurse’s role. mately 1 out of 50 people, or 5 to 7.5 million people in the US, according to Keywords: behavioral health, body the Anxiety and Depression Association SHUTTERSTOCK / EU dysmorphic disorder, dysmorphia, of America (ADAA).2,3 Individuals who . mental health, obsessive-compulsive have BDD spend a great deal of time disorder, social media focusing on perceived flaws and ways in PHOTOGRAPHEE 28 l Nursing2019 l Volume 49, Number 3 www.Nursing2019.com Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved. www.Nursing2019.com March l Nursing2019 l 29 Copyright © 2019 Wolters Kluwer Health, Inc.
    [Show full text]
  • Secondary Enuresis & Body Dysmorphic Disorder in A
    Psychiatria Danubina, 2010; Vol. 22, Suppl. 1, pp 53–55 Conference paper © Medicinska naklada - Zagreb, Croatia SECONDARY ENURESIS & BODY DYSMORPHIC DISORDER IN A CAUCASIAN MALE WITH CATATONIC SCHIZOPHRENIA: A case report Nuruz Zaman, Milind Karale & Mark Agius South Essex Partnership University Foundation NHS Trust, UK SUMMARY We describe a patient with Schizophrenia and secondary enuresis. The enuresis settled with resolution of his psychotic symptoms but later remerged after starting Clozapine. We explore the mechanisms of incontinence in Schizophrenia and those due to Clozapine. This case highlights the need to inquire about incontinence in patients with schizophrenia prior to prescribing clozapine. Key words: schizophrenia – enuresis – clozapine – incontinence - body dysmorphic disorder * * * * * Introduction Clozapine. This case highlights the need to inquire about incontinence in patients with schizophrenia prior Urinary incontinence in patients with schizophrenia to prescribing clozapine. can present with daytime urinary leakage, urge incontinence and bed wetting. The association between Case Report bedwetting and schizophrenia has been noted since the pre neuroleptic era when Kraeplin reported a group of Mr AP is a 21 year old man who was referred to an schizophrenic patients with resistant incontinence. child and adolescent outpatient clinic at the age of 17 Various mechanisms have been postulated for this with a six month history of not coping with training and association. The ventricular enlargement (hydrocepha- educational tasks. He had low mood, poor self esteem, lus), selective neuronal loss with gliosis, and dopamine occasional aggressive outbursts and certain compulsion dysregulation in schizophrenia may indicate a like repeatedly checking doors, windows and mirrors. neurological basis to the incontinence. These anatomical He walked with his hand over his nose and perceived lesions might interrupt the pathways of bladder control people to be laughing at his nose.
    [Show full text]
  • Anxiety Disorders
    Anxiety disorders Quality standard Published: 6 February 2014 www.nice.org.uk/guidance/qs53 © NICE 2019. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights). Anxiety disorders (QS53) Contents Introduction ......................................................................................................................................................................... 4 Why this quality standard is needed ........................................................................................................................................ 4 How this quality standard supports delivery of outcome frameworks...................................................................... 6 Coordinated services...................................................................................................................................................................... 11 List of quality statements................................................................................................................................................ 12 Quality statement 1: Assessment of suspected anxiety disorders ................................................................ 13 Quality statement............................................................................................................................................................................ 13 Rationale ............................................................................................................................................................................................
    [Show full text]
  • (Or Body Dysmorphic Disorder) and Schizophrenia: a Case Report
    CASE REPORT Afr J Psychiatry 2010;13:61-63 Delusional disorder-somatic type (or body dysmorphic disorder) and schizophrenia: a case report BA Issa Department of Behavioural Sciences, College of Health Sciences, University of Ilorin, Nigeria Abstract With regard to delusional disorder-somatic subtype there may be a relationship with body dysmorphic disorder. There are reports that some delusional disorders can evolve to become schizophrenia. Similarly, the treatment of such disorders with antipsychotics has been documented. This report describes a case of delusional disorder - somatic type - preceding a psychotic episode and its successful treatment with an antipsychotic drug, thus contributing to what has been documented on the subject. Key words: Delusional disorder; Somatic; Body dysmorphic disorder; Schizophrenia Received: 14-10-2008 Accepted: 03-02-2009 Introduction may take place. While some successes have been reported, The classification of body dysmorphic disorder (BDD) is the general consensus is that most cases need psychiatric controversial; whereas BDD is classified as a somatoform rather than surgical intervention and that surgery may disorder, its delusional variant is classified as a psychotic seriously worsen the mental disorder in the longer term. 7 disorder. 1,2 This psychotic variant is also referred to as A previous or family history of psychotic disorder is delusional disorder somatic type. It is sometimes very difficult uncommon and in younger patients, a history of substance to distinguish cases of delusional disorder of somatic subtype abuse or head injury is frequent. 8 Although anger and hostility from severe somatization disorder, and claims have been are commonplace, shame, depression, and avoidant behavior made that there is a continuum between these illnesses.
    [Show full text]
  • Body Dysmorphic Disorder (BDD)
    © Mind 2018 Body dysmorphic disorder (BDD) Explains what body dysmorphic disorder (BDD) is, the symptoms and possible causes of BDD and how you can access treatment and support. Includes tips for helping yourself, and advice for friends and family. If you require this information in Word document format for compatibility with screen readers, please email: [email protected] Contents What is body dysmorphic disorder (BDD)? .......................................................................... 2 What are the common signs and symptoms of BDD? .......................................................... 2 What causes BDD? .............................................................................................................. 4 What treatments are available for BDD? ............................................................................. 6 What can I do to help myself? .............................................................................................. 8 How can friends and family help?........................................................................................ 9 Useful contacts .................................................................................................................... 10 1 © Mind 2018 What is body dysmorphic disorder (BDD)? Body dysmorphic disorder (BDD) is an anxiety disorder related to body image. You might be given a diagnosis of BDD if you: experience obsessive worries about one or more perceived flaws in your physical appearance, and the flaw cannot be seen by others or
    [Show full text]
  • New Perspectives in the Treatment of Body Dysmorphic
    F1000Research 2018, 7(F1000 Faculty Rev):361 Last updated: 17 JUL 2019 REVIEW New perspectives in the treatment of body dysmorphic disorder [version 1; peer review: 2 approved] Kevin Hong , Vera Nezgovorova, Eric Hollander Department of Psychiatry and Behavioral Sciences, Autism and Obsessive-Compulsive Spectrum Program, Anxiety and Depression Program, Albert Einstein College of Medicine, Montiefiore Medical Center, The Bronx, New York, USA First published: 23 Mar 2018, 7(F1000 Faculty Rev):361 ( Open Peer Review v1 https://doi.org/10.12688/f1000research.13700.1) Latest published: 23 Mar 2018, 7(F1000 Faculty Rev):361 ( https://doi.org/10.12688/f1000research.13700.1) Reviewer Status Abstract Invited Reviewers Body dysmorphic disorder (BDD) is a disabling illness with a high 1 2 worldwide prevalence. Patients demonstrate a debilitating preoccupation with one or more perceived defects, often marked by poor insight or version 1 delusional convictions. Multiple studies have suggested that selective published serotonin reuptake inhibitors and various cognitive behavioral therapy 23 Mar 2018 modalities are effective first-line treatments in decreasing BDD severity, relieving depressive symptoms, restoring insight, and increasing quality of life. Selective serotonin reuptake inhibitors have also recently been shown F1000 Faculty Reviews are written by members of to be effective for relapse prevention. This review provides a the prestigious F1000 Faculty. They are comprehensive summary of the current understanding of BDD, including its commissioned and are peer reviewed before clinical features, epidemiology, genetics, and current treatment modalities. publication to ensure that the final, published version Additional research is needed to fully elucidate the relationship between BDD and comorbid illnesses such as obsessive–compulsive-related is comprehensive and accessible.
    [Show full text]
  • What Is Body Dysmorphic Disorder (BDD)? • Thinking Too Much About an Imagined Or Slight Flaw in a Person’S Own Looks
    What is Body Dysmorphic Disorder (BDD)? • Thinking too much about an imagined or slight flaw in a person’s own looks. (APA, 2000). If there is a slight flaw, the person’s concern is extreme. • These unhappy feelings are consuming. These feelings cause harmful beliefs and attitudes that affect thoughts, emotions and behaviors. These can then harm all areas of a person’s life, such as their social activities and job. • No other mental disorder, for example eating disorders, cause these consuming feelings. What are the common signs and symptoms of BDD? • Fixation and thoughts about appearance • Mirror checking-Spending too much time staring in a mirror/shiny surface at the real or imagined flaw • Avoidance of mirrors/shiny surfaces • Their belief is very strong even if evidence does not support it (this is also called Overvalued Ideation or OVI) • Covering up the “afflicted area.” (e.g. hats, scarves, make-up) • Repeatedly asking others to tell them that they look okay (also referred to as ‘reassurance seeking’). • Frequent unnecessary appointments with medical professionals/surgeons • Repeated unnecessary plastic surgery • Compulsive skin picking. Often, nails and tweezers are used to remove blemishes/hair. • Avoiding social situations, public places, work, school, etc... • Leaving the house less often or only going out at night to prevent others from seeing the “flaw”. • Keeping the obsessions and compulsions secret due to feelings of shame. • Emotional problems, such as feelings of disgust, depression, anxiety, low self-esteem, etc. How do you tell the difference between being unhappy with a part of your appearance and BDD? Many people are unhappy with some part of the way they look, however, this is on a continuum.
    [Show full text]
  • Body Dysmorphic Disorder: a Diagnostic Challenge in Adolescence
    South African Journal of Psychiatry ISSN: (Online) 2078-6786, (Print) 1608-9685 Page 1 of 4 Case Report Body dysmorphic disorder: A diagnostic challenge in adolescence Authors: Body dysmorphic disorder (BDD) is a chronic and disabling condition that is characterised by 1,2 Yanga Thungana distressing preoccupations with perceived defects in one’s own appearance, which might be Karis Moxley1 Anusha Lachman1 slight or not observable to others. It is considered to be an obsessive–compulsive spectrum disorder and is associated with depression, feelings of shame and poor quality of life. It is Affiliations: primarily a disorder of childhood or adolescent onset, and sub-clinical BDD symptoms begin, 1 Department of Psychiatry, on average, several years before an individual’s symptoms meet full criteria for the disorder. Stellenbosch University, South Africa Here we report the case of an adolescent admitted to an inpatient psychiatric unit for treatment of psychotic symptoms that were poorly responsive to standard treatments. This challenging 2Department of Psychiatry, case of BDD in an adolescent highlights the various comorbidities of the disorder, as well as Walter Sisulu University, the difficulties associated with BDD diagnosis. South Africa Corresponding author: Karis Moxley, Background [email protected] Body dysmorphic disorder (BDD) is a common, chronic and disabling disorder that is often Dates: under-recognised and misdiagnosed. It consists of severe preoccupations with one or more Received: 23 Mar. 2017 defects in physical appearance, which are objectively slight or not noticeable to others. The Accepted: 11 May 2018 concerns result in feelings of shame or unworthiness, psychological distress or depression, and Published: 28 June 2018 poor quality of life.1 Body dysmorphic disorder is often diagnosed in adulthood but is primarily How to cite this article: a disorder of childhood or adolescent onset.
    [Show full text]
  • Comorbid Social Anxiety and Body Dysmorphic Disorder: Managing the Complicated Patient
    Social Anxiety and Body Dysmorphic Disorder Comorbid Social Anxiety and Body Dysmorphic Disorder: Managing the Complicated Patient Eric Hollander, M.D., and Bonnie R. Aronowitz, Ph.D. © CopyrightPatients with body dysmorphic2000 Physiciansdisorder (BDD) have anPostgraduate obsessive preoccupation Press,with an imagined Inc. defect in appearance or, if a slight physical abnormality exists, a grossly excessive concern with it. This preoccupation causes significant distress or impairment of social, occupational, or other functioning. So- cial anxiety is a prominent component of BDD, and social avoidance resulting from BDD symptoms may markedly impair social functioning. In severe cases, avoidance of social situations in combination with occupational and academic impairment may result in patients becoming housebound. The prevalence of BDD is 1% to 2% in the U.S. population and 11% to 12% in patients with social anxiety disorder. Behav- iors associated with BDD include mirror checking, physician visits, hair grooming, use of cosmetics, and social avoidance. Distress over BDD may lead patients to undergo repeated cosmetic surgeries in futile at- tempts to conceal or correct perceived defects. Additionally, depression and suicide are frequent complica- tions of BDD. Pharmacologic and nonpharmacologic treatments for the management of BDD with coexist- ing social anxiety are presented in this article. (J Clin Psychiatry 1999;60[suppl 9]:27–31) One personal copy may be printed ody dysmorphic disorder (BDD) has been termed Diagnostic probes for
    [Show full text]
  • Reflecting on Body Dysmorphic Disorder
    October 2020 ReCent Medical News Symptoms of BDD can be a compulsion to look in mirrors or avoid them altogether. Reflecting on body dysmorphic disorder The largest group affected by BDD are younger adults and Did you know? teenagers. Epidemiological nationwide studies show a consistently slightly higher female prevalence. 3 In clinical settings BDD is quite common, especially in the areas of Studies suggest body dysmorphic disorder affects dermatology, cosmetic surgery and mental health.4 about 1 in 50 of the general population, though prevalence may be much higher. There are a number of symptoms of BDD. The sufferer may worry excessively about an area of the body, particularly the face. They may devote too much time to comparing their appearance with others. There can be a compulsion to look Body dysmorphic disorder (BDD) was first described in 1891 in mirrors or avoid them altogether. In many cases, a lot of as “dysmorphophobia” by Enrico Morselli, an Italian time is spent trying to conceal perceived flaws and there can psychiatrist.1 It is an obsession with perceived flaws in one’s be repetitive picking at the skin. A large number of BDD own appearance that will most likely appear insignificant or sufferers will have these obsessions for long periods of the unobservable to others. This article will look at BDD in more day, which can be detrimental to daily functioning. detail and cover the potential implications for obtaining insurance. As with other mental health disorders, biopsychosocial elements are thought to play a part in the development of What causes BDD and who is affected? BDD.
    [Show full text]
  • Occupational Functioning and Impairment in Adults with Body Dysmorphic Disorder ⁎ Elizabeth R
    Available online at www.sciencedirect.com Comprehensive Psychiatry 49 (2008) 561–569 www.elsevier.com/locate/comppsych Occupational functioning and impairment in adults with body dysmorphic disorder ⁎ Elizabeth R. Didiea,b, , William Menarda, Adam P. Sternc, Katharine A. Phillipsa,b aButler Hospital, Providence, RI 02906, USA bDepartment of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI 02912, USA cBrown University, Providence, RI 02912, USA Abstract Objective: Body dysmorphic disorder (BDD) is relatively common and appears to be associated with marked impairment in psychosocial functioning. Previous reports, however, did not investigate occupational functioning in detail, assess impairment specifically in occupational functioning using standardized measures in a nontreatment seeking sample, or examine correlates of occupational impairment. Methods: Occupational functioning and other clinical variables were assessed in 141 adults with BDD. Measures included the Range of Impaired Functioning Tool and other reliable and valid self-report and interviewer-administered measures. Results: Fewer than half of subjects were working full-time, and 22.7% were receiving disability pay. Thirty-nine percent of the sample reported not working in the past month because of psychopathology. Of those subjects who worked in the past month, 79.7% reported impairment in work functioning because of psychopathology. Adults with BDD who were not working because of psychopathology were comparable to subjects who
    [Show full text]
  • Psychosis in Body Dysmorphic Disorder
    Journal of Psychiatric Research 38 (2004) 63–72 www.elsevier.com/locate/jpsychires Psychosis in body dysmorphic disorder Katharine A. Phillips* Butler Hospital and The Department of Psychiatry and Human Behavior, Brown Medical School, 345 Blackstone Boulevard, Providence, RI 02906, USA Received 2 August 2002; received in revised form 3 December 2002; accepted 10 December 2002 Abstract Body dysmorphic disorder (BDD) has both psychotic and nonpsychotic variants, which are classified as separate disorders in DSM-IV (delusional disorder and a somatoform disorder). Despite their separate classification, available evidence indicates that BDD’s delusional and nondelusional forms have many similarities (although the delusional variant appears more severe), suggest- ing that they may actually be the same disorder, characterized by a spectrum of insight. And contrary to what might be expected, BDD’s delusional form, although classified as a psychotic disorder, appears to respond to serotonin-reuptake inhibitors alone. These and other data suggest that a dimensional view of psychosis (in particular, delusions) in these disorders may be more accurate than DSM’s current categorical view. A dimensional model might also facilitate more consistent and accurate classification of other disorders that are likely characterized by a spectrum of insight, such as obsessive compulsive disorder, hypochondriasis, and anor- exia nervosa. Further research is needed to better understand these classification issues, which likely have treatment implications. # 2003 Elsevier Ltd. All rights reserved. Keywords: Body Dysmorphic Disorder; Dysmorphophobia; Delusional disorder; Psychosis; Delusions; Classification 1. Introduction appearance, is still in its early stages. Nonetheless, this disorder’s psychotic features have been of interest and Body dysmorphic disorder (BDD) inhabits a place in the focus of research.
    [Show full text]